Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in shares of Stryker Corporation (NYSE:SYK) by 2.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,781 shares of the medical technology company’s stock after purchasing an additional 1,819 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Stryker Corporation were worth $11,757,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds also recently modified their holdings of the company. Acrospire Investment Management LLC purchased a new position in Stryker Corporation during the second quarter valued at approximately $111,000. Motco grew its holdings in Stryker Corporation by 50.7% in the second quarter. Motco now owns 826 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 278 shares during the period. Bollard Group LLC grew its holdings in Stryker Corporation by 0.4% in the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 3 shares during the period. Bruderman Asset Management LLC acquired a new stake in Stryker Corporation in the second quarter valued at approximately $150,000. Finally, James Investment Research Inc. acquired a new stake in Stryker Corporation in the second quarter valued at approximately $155,000. 74.15% of the stock is currently owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: “Fjarde AP Fonden Fourth Swedish National Pension Fund Buys 1,819 Shares of Stryker Corporation (SYK)” was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://ledgergazette.com/2017/11/15/fjarde-ap-fonden-fourth-swedish-national-pension-fund-buys-1819-shares-of-stryker-corporation-syk.html.
Shares of Stryker Corporation (SYK) traded up $0.20 during midday trading on Wednesday, hitting $155.95. The company had a trading volume of 1,011,700 shares, compared to its average volume of 1,181,533. The firm has a market cap of $58,287.51, a PE ratio of 24.68, a PEG ratio of 2.45 and a beta of 0.79. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63. Stryker Corporation has a 1 year low of $107.13 and a 1 year high of $160.62.
Stryker Corporation (NYSE:SYK) last announced its earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.50 by $0.02. The firm had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.97 billion. Stryker Corporation had a return on equity of 24.11% and a net margin of 14.67%. The business’s revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.39 EPS. research analysts forecast that Stryker Corporation will post 6.47 EPS for the current year.
A number of analysts have recently issued reports on SYK shares. Zacks Investment Research lowered Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Royal Bank Of Canada lifted their price target on Stryker Corporation from $140.00 to $155.00 and gave the stock an “outperform” rating in a research note on Friday, July 28th. Oppenheimer Holdings, Inc. set a $148.00 price target on Stryker Corporation and gave the stock a “hold” rating in a research note on Friday, July 28th. Stifel Nicolaus lifted their price target on Stryker Corporation from $151.00 to $158.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. Finally, Cowen and Company reaffirmed a “buy” rating and issued a $160.00 price target (up from $150.00) on shares of Stryker Corporation in a research note on Sunday, July 30th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and thirteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $151.52.
In other news, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $155.34, for a total transaction of $776,700.00. Following the completion of the transaction, the insider now directly owns 83,207 shares of the company’s stock, valued at approximately $12,925,375.38. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 7.40% of the stock is owned by corporate insiders.
Stryker Corporation Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.